CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 57,843	$ 42,972
Selling, general and administrative	32,579	14,395
Total operating expenses	90,422	57,367
Loss from operations	(90,422)	(57,367)
Other income (expense):
Research and development incentives	420	438
Investment income	4,714	4,711
Interest expense on finance lease liability	(521)	(534)
Interest expense on debt obligations	(1,475)	(1,426)
Other income (expense)	591	406
Total other income (expense), net	3,729	3,595
Net loss	$ (86,693)	$ (53,772)
Net loss per common share, basic (in dollars per share)	$ (0.95)	$ (0.78)
Net loss per common share, diluted (in dollars per share)	$ (0.95)	$ (0.78)
Weighted average common shares outstanding, basic (in shares)	91,516,199	69,185,885
Weighted average common shares outstanding, diluted (in shares)	91,516,199	69,185,885